FATE THERAPEUTICS INC (FATE) Stock Balance Sheet
NASDAQ:FATE - Nasdaq - US31189P1021 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 44.92M | 36.06M | 41.87M | 61.30M | 133.60M | |||
| Marketable Securities | 195.50M | 243.01M | 273.31M | 374.90M | 482.30M | |||
| Receivables | 2.41M | 3.54M | 1.83M | 38.50M | 8.70M | |||
| Other Current Assets | 5.39M | 9.30M | 14.54M | 27.40M | 8.80M | |||
| Total Current Assets | 248.22M | 291.91M | 331.54M | 502.10M | 633.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 107.94M | 110.89M | 158.51M | 176.10M | 162.20M | |||
| Investments And Advances | 32.29M | 27.66M | 980.00K | 4.90M | 100.70M | |||
| Other Non-Current Assets | 10.23M | 10.24M | 15.19M | 15.30M | 15.30M | |||
| Total Non-Current Assets | 150.45M | 148.78M | 174.68M | 203.50M | 288.10M | |||
| TOTAL ASSETS | 398.67M | 440.69M | 506.22M | 705.60M | 921.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 23.76M | 28.76M | 33.69M | 59.60M | 48.00M | |||
| Accounts Payable | 4.19M | 9.37M | 4.72M | 8.30M | 8.60M | |||
| Other Current Liabilities | 212.00K | 393.00K | 685.00K | 46.20M | 24.70M | |||
| Total Current Liabilities | 28.16M | 38.52M | 39.09M | 114.10M | 81.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 82.10M | 83.45M | 98.71M | 107.60M | 161.30M | |||
| Total Non-Current Liabilities | 82.10M | 83.45M | 98.71M | 107.50M | 161.30M | |||
| TOTAL LIABILITIES | 110.26M | 121.97M | 137.80M | 221.60M | 242.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.44B | -1.40B | -1.21B | -1.05B | -769.10M | |||
| Additional Paid In Capital | 1.72B | 1.72B | 1.58B | 1.54B | 1.45B | |||
| Common Shares | 118.00K | 117.00K | 102.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 191.00K | 268.00K | 15.00K | -1.90M | -800.00K | |||
| Shares Outstanding | 114.60M | 113.93M | 98.63M | 97.30M | 95.70M | |||
| Tangible Book Value per Share | 2.52 | 2.80 | 3.74 | 4.97 | 7.09 | |||
| Total Shareholders' Equity | 288.41M | 318.73M | 368.42M | 483.90M | 678.80M | |||
| TOTAL LIABILITIES AND EQUITY | 398.67M | 440.69M | 506.22M | 705.60M | 921.50M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 8.81 | 7.58 | 8.48 | 4.40 | 7.79 | |||
| Return On Assets (ROA) | -44.12% | -42.27% | -31.79% | -39.93% | -23.02% | |||
| Return On Equity (ROE) | -60.98% | -58.44% | -43.68% | -58.22% | -31.25% | |||
All data in USD , ROIC based on taxRate of 0.21